Skip to content
Women’s Health & Wellness cover art

All episodes

Women’s Health & Wellness, 1,000 episodes. Page 1 of 10.

#
Title
1

Is Menopause Behind Your Pain? The Symptoms You Shouldn't Ignore

2

Which barrier-care principles matter after intimate pigment treatment?

3

Menopause, Mental Health & Self-Care: Stop Putting Yourself Last | Menopause Mindset and Therapy

4

What causes intimate post-inflammatory hyperpigmentation?

5

Can intimate depigmentation peels be combined with PN or skin boosters?

6

When can normal activities resume after intimate depigmentation?

7

Can pigment lasers be used safely for vulval skin lightening?

8

Why does Fitzpatrick skin type matter before intimate laser or peel treatment?

9

Can intimate lightening be considered with stable lichen sclerosus or eczema?

10

Why is patch testing important before intimate lightening acids?

11

How do pregnancy or PCOS affect intimate pigmentation treatment?

12

How can intimate brightening results be maintained safely?

13

Why are unregulated bleaching creams unsafe for vulval tissue?

14

Can topical tranexamic acid or glutathione calm vulval melanocyte activity?

15

How many sessions might intimate skin brightening need?

16

How is melanin-rich intimate skin prepared before peels?

17

How does age-related elastic-fibre loss affect SUI treatment durability?

18

How does friction from clothing or sport worsen intimate skin darkening?

19

How do intimate chemical peels affect tyrosinase and vulval pigmentation?

20

How does perianal pigmentation treatment differ from labial darkening?

21

How should redness or flaking after intimate depigmentation be assessed?

22

Can exosome signalling affect hypertrophic scar formation after vulval wounds?

23

When should severe SUI be triaged to bulking agents or surgical options?

24

How is mixed urinary incontinence screened before regenerative SUI treatment?

25

How does intrinsic sphincter deficiency differ from urethral hypermobility?

26

What should patients know about safety before periurethral regenerative injections?

27

Can exosomes or polynucleotides restore the urethral mucosal cushion?

28

What aftercare issues matter after sub-urethral tissue treatment?

29

Can HA skin boosters cushion tissue under the urethral meatus?

30

Can injectable biostimulants be combined with HIFEM pelvic-floor training?

31

Which urodynamic tests evaluate regenerative SUI treatment response?

32

How should old childbirth scars be assessed before regenerative injections?

33

Can regenerative biostimulation help pudendal nerve stretch injury?

34

How are pain scores tracked during scar-treatment follow-up?

35

Can local vaginal oestrogen preparation affect response to SUI energy devices?

36

How should treatment scheduling for sub-urethral fascia contraction be discussed?

37

Can regenerative SUI treatment be considered after failed PFMT or sling surgery?

38

Can regenerative SUI treatments help urinary leaking during sex?

39

Can Erbium:YAG laser tighten sub-urethral fascia for urinary control?

40

Can down-training be combined with regenerative injectables for postpartum vaginismus?

41

Can radiofrequency and scar massage improve perineal elasticity?

42

Can radiofrequency improve urethral coaptation during coughing or sneezing?

43

Can transperineal ultrasound show bladder-neck mobility after SUI treatment?

44

How should expectations be set for non-surgical scar remodelling versus surgical revision?

45

Can PRP support pubourethral ligament collagen in stress leaking?

46

How can wound breakdown risk be reduced near a healed episiotomy scar?

47

Can non-surgical treatment help introital gaping without obvious prolapse?

48

Can polynucleotides help entry friction after uneven perineal healing?

49

Can fractional CO2 laser reduce tissue micro-fissuring linked with recurrent UTIs?

50

How might vaginal epithelial thickening affect glycogen and Lactobacillus?

51

Can mucosal rehydration reduce urethral friction during intercourse?

52

Can better sub-mucosal blood flow support local IgA immune defence?

53

Can regenerative biostimulation help UTI-like urethral burning?

54

Can polynucleotide boosters be combined with D-mannose for recurrent UTIs?

55

Can energy-based mucosal treatment prevent recurrent BV or cytolytic vaginosis flares?

56

What precautions reduce infection risk during injectables for chronic UTI sufferers?

57

How should regenerative treatment be timed around prophylactic antibiotics?

58

Can HA skin boosters cushion fibrous childbirth scars?

59

Can treating severe GSM help break the cycle of post-coital cystitis?

60

When should scar remodelling treatment be considered after instrumental delivery?

61

Can exosome signalling calm inflammatory cytokines around the urethra?

62

Can regenerative treatments lower vaginal pH back towards a healthy range?

63

Can polynucleotides or exosomes soften painful episiotomy scar tissue?

64

Can skin-booster biorevitalisation improve bladder-neck mucosal support?

65

Can regenerative treatment help painful sex after a tight perineal repair?

66

Can RF microneedling help fibrous adhesions after a third-degree tear?

67

Can polynucleotide or exosome injections strengthen the bladder lining?

68

How do clinicians check vaginal microbiome stability before regenerative injectables?

69

Can PRP reduce E. coli adhesion around the urethra?

70

Which tests track urogenital barrier recovery after treatment?

71

Can non-surgical care support a partial puborectalis tear?

72

Can PRP help persistent scar sensitivity after childbirth?

73

Can regenerative treatment restore Skene's gland antimicrobial secretions?

74

How is levator ani avulsion assessed with 3D pelvic-floor ultrasound?

75

How might HIFEM affect leakage during coughing or exercise?

76

Can HIFEM support postpartum pelvic-floor recovery?

77

How does HIFEM differ for leakage versus pelvic-floor guarding?

78

How are fatigue and recovery considered during HIFEM treatment?

79

Can HIFEM pelvic-floor chair sessions be combined with RF?

80

Why can metal hip or spine implants affect HIFEM suitability?

81

Why does positioning matter during HIFEM pelvic-floor treatment?

82

Can HIFEM be combined with polynucleotide or exosome treatments?

83

Can HIFEM affect pelvic-floor blood circulation?

84

Can HIFEM help vaginal laxity symptoms by strengthening pelvic-floor support?

85

Can HIFEM help uncoordinated pelvic-floor release in mild dyspareunia?

86

How do HIFEM fields create supramaximal pelvic-floor contractions?

87

How can sEMG scores measure pelvic-floor change after HIFEM?

88

How can HIFEM train different pelvic-floor muscle fibres?

89

How should HIFEM maintenance sessions be planned?

90

How does HIFEM magnetic stimulation activate pelvic-floor nerves?

91

Can you have HIFEM pelvic-floor treatment with an IUD or coil?

92

Is there a standard HIFEM course for pelvic-floor strengthening?

93

How do HA skin boosters compare with PRP for vulval hydration?

94

Can topical anaesthetic affect skin-booster comfort or planning?

95

How is skin-booster mesotherapy different from filler cannula treatment?

96

Can skin-booster osmolality affect stinging or burning?

97

Is there a standard course schedule for intimate skin boosters?

98

How do different vaginal RF systems deliver energy through tissue?

99

What role does glycerol play in HA skin boosters?

100

Can vulval skin boosters help dry-skin itching?